RT Journal Article
SR Electronic
T1 Genetically Predicted Inflammatory Proteins Mediate the Association Between Gut Microbiota and Preterm Delivery: A Mendelian Randomization Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.22.24315951
DO 10.1101/2024.10.22.24315951
A1 Zhang, Min
A1 Chen, Xiaodan
A1 Zhang, Yan
A1 Huang, Jia
A1 Chen, Ling
YR 2024
UL http://medrxiv.org/content/early/2024/10/23/2024.10.22.24315951.abstract
AB Aims Inflammatory proteins and unique gut microbiota profiles characterize preterm delivery (PTD). Nevertheless, the comprehensive understanding of gut microbiota and inflammatory proteins of PTD remains unclear. This study aimed to investigate the causal relationship between gut microbiota and PTD and identify the inflammatory proteins as potential mediators.Methods and results The exposure genome-wide association studies (GWAS) data were sourced from the GWAS Catalog, while the outcome GWAS data were obtained from the Early Growth Genetics (EGG) Consortium. The study used 473 types of gut microbiota, 91 types of inflammatory proteins, and PTD from GWAS. We then performed two-sample Mendelian randomization (TSMR) and bidirectional Mendelian randomization (BDMR) analyses to explore the causal relationships between gut microbiota, inflammatory proteins, and PTD. Additionally, we conducted two-step Mendelian randomization (2SMR) to identify potential mediating inflammatory proteins in this process. MR analysis identified 26 gut microbiota and 6 types of inflammatory proteins causally associated with PTD. Furthermore, there was no strong evidence that genetically predicted PTD affected these gut microbiota and inflammatory proteins. Further, 2SMR analysis revealed that the association between Elusimicrobiaceae and PTD was mediated by the C-C motif chemokine 23 (CCL23), accounting for 5.09% (95%CI; 4.1%-8.7%) of the association. Similarly, the relationship between Thioalkalivibrionaceae and PTD was mediated by the Interleukin-20 receptor subunit alpha (IL-20RA), which accounted for 16.88% (95%CI; 12.77%-20.99%) of the association.Conclusions Our results reveal that Elusimicrobiaceae and Thioalkalivibrionaceae were significantly associated with PTD, with mediation occurring via CCL23 and IL-20RA, respectively.Impact Statement This study establishes a causal link between specific gut microbiota, inflammatory proteins, and PTD through MR analyses. The findings indicate that targeting the pathways involving Elusimicrobiaceae - CCL23 - PTD and Thioalkalivibrionaceae - IL20RA - PTD may provide promising interventions for preventing and treating PTD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Shanghai Pudong New District Health Commission Health Science and Technology Project (Grant numbers PW2021A-76).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The analysis utilized publicly available datasets. Detailed information on all original contributions can be found in the "Data Sources" section, including specific download links and accession numbers. Readers can refer to this section for access. For further inquiries, please contact the corresponding author.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe analysis utilized publicly available datasets. Detailed information on all original contributions can be found in the "Data Sources" section, including specific download links and accession numbers. Readers can refer to this section for access. For further inquiries, please contact the corresponding author. https://www.ebi.ac.uk/gwas/ http://egg-consortium.org/